(Q38195671)

30 August 2017

1 reference

title

Blockade of CXCR2 signalling: a potential therapeutic target for preventing neutrophil-mediated inflammatory diseases (English)

1 reference

30 August 2017

0 references

0 references

Nithin B Boppana

1

1 reference

30 August 2017

Asokan Devarajan

2

1 reference

30 August 2017

Kaliappan Gopal

3

1 reference

30 August 2017

Muttiah Barathan

4

1 reference

30 August 2017

Sazaly A Bakar

5

1 reference

30 August 2017

Esaki M Shankar

6

1 reference

30 August 2017

Abdul S Ebrahim

7

1 reference

30 August 2017

Shukkur M Farooq

8

1 reference

30 August 2017

13 March 2014

1 reference

Experimental Biology and Medicine

30 August 2017

1 reference

30 August 2017

239

1 reference

30 August 2017

5

1 reference

30 August 2017

509-518

1 reference

Getting leukocytes to the site of inflammation

30 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

Getting to the site of inflammation: the leukocyte adhesion cascade updated

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

Neutrophil-active chemokines in in vivo imaging of neutrophil trafficking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

Recent advances reveal IL-8 signaling as a potential key to targeting breast cancer stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

Blockade of the chemokine receptor CXCR2 ameliorates adjuvant-induced arthritis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

ELR+ CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

The functional significance behind expressing two IL-8 receptor types on PMN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

Inhibition of CXCR1 and CXCR2 chemokine receptors attenuates acute inflammation, preserves gray matter and diminishes autonomic dysreflexia after spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

Assignment of genes for interleukin-8 receptors (IL8R) A and B to human chromosome band 2q35

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

Cloning of complementary DNA encoding a functional human interleukin-8 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

Molecular characterization of receptors for human interleukin-8, GRO/melanoma growth-stimulatory activity and neutrophil activating peptide-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

CXC chemokine receptor-1 is expressed by hepatocytes and regulates liver recovery after hepatic ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

CXC receptor-1 silencing inhibits androgen-independent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

Chemokine receptor expression by mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

Targeting CXCR2 enhances chemotherapeutic response, inhibits mammary tumor growth, angiogenesis, and lung metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

Chemokine receptor CXCR2: physiology regulator and neuroinflammation controller?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

Chemokine contribution to neuropathic pain: respective induction of CXCL1 and CXCR2 in spinal cord astrocytes and neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

Effects of epithelial and neutrophil CXCR2 on innate immunity and resistance to kidney infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

A chemokine self-presentation mechanism involving formation of endothelial surface microstructures

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

Neutrophil chemotaxis caused by chronic obstructive pulmonary disease alveolar macrophages: the role of CXCL8 and the receptors CXCR1/CXCR2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

The chemokine receptor CXCR2 and coronavirus-induced neurologic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

The oxysterol-CXCR2 axis plays a key role in the recruitment of tumor-promoting neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

Chemokine CXCL1 dimer is a potent agonist for the CXCR2 receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

The CXCR1/2 ligand NAP-2 promotes directed intravascular leukocyte migration through platelet thrombi

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

CXCR2 is essential for maximal neutrophil recruitment and methacholine responsiveness after ozone exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

CXCR2: From Bench to Bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

Unraveling the chemistry of chemokine receptor ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

New therapeutics that modulate chemokine networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

CXCR2 antagonists block the N-Ac-PGP-induced neutrophil influx in the airways of mice, but not the production of the chemokine CXCL1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

CXCR2 antagonists for the treatment of pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

Nicotinanilides as inhibitors of neutrophil chemotaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

Noncompetitive allosteric inhibitors of the inflammatory chemokine receptors CXCR1 and CXCR2: prevention of reperfusion injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

Treatment with DF 2162, a non-competitive allosteric inhibitor of CXCR1/2, diminishes neutrophil influx and inflammatory hypernociception in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

CXCR2 in acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

A novel, orally active CXCR1/2 receptor antagonist, Sch527123, inhibits neutrophil recruitment, mucus production, and goblet cell hyperplasia in animal models of pulmonary inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

Imidazolylpyrimidine based CXCR2 chemokine receptor antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

Selective inhibition of interleukin-8-induced neutrophil chemotaxis by ketoprofen isomers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

Role of CXCR2 in cigarette smoke-induced lung inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

CXCR2 is critical for dsRNA-induced lung injury: relevance to viral lung infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

Importance of CXC chemokine receptor 2 in alveolar neutrophil and exudate macrophage recruitment in response to pneumococcal lung infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

CXC chemokine receptor CXCR2 is essential for protective innate host response in murine Pseudomonas aeruginosa pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

Bacterial clearance and survival are dependent on CXC chemokine receptor-2 ligands in a murine model of pulmonary Nocardia asteroides infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

Chemokines: immunology's high impact factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

Chemokines in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

CXCR2 chemokine receptor antagonism enhances DOP opioid receptor function via allosteric regulation of the CXCR2-DOP receptor heterodimer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

Targeted drug-delivery approaches by nanoparticulate carriers in the therapy of inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

Potential prospects of nanomedicine for targeted therapeutics in inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

Contrasting roles for CXCR2 during experimental colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

Crucial pathophysiological role of CXCR2 in experimental ulcerative colitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

Immunomodulatory role of CXCR2 during experimental septic peritonitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

The selective nonpeptide CXCR2 antagonist SB225002 ameliorates acute experimental colitis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

SB265610 is an allosteric, inverse agonist at the human CXCR2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

SCH527123, a novel CXCR2 antagonist, inhibits ozone-induced neutrophilia in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

A synthetic, non-peptide CXCR2 antagonist blocks MIP-2-induced neutrophil migration in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

Antileukinate, a hexapeptide inhibitor of CXC-chemokine receptor, suppresses bleomycin-induced acute lung injury in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

Therapeutic inhibition of CXCR2 by Reparixin attenuates acute lung injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

Neuroprotection with the CXCL8 inhibitor repertaxin in transient brain ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

Carboxylic acid bioisosteres acylsulfonamides, acylsulfamides, and sulfonylureas as novel antagonists of the CXCR2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

SB-656933, a novel CXCR2 selective antagonist, inhibits ex vivo neutrophil activation and ozone-induced airway inflammation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

CXCR2 blockade impairs angiotensin II-induced CC chemokine synthesis and mononuclear leukocyte infiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

Humanized forms of the CXCR1/CXCR2 antagonist, bovine CXCL8((3-74))K11R/G31P, effectively block ELR-CXC chemokine activity and airway endotoxemia pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

A potent and selective nonpeptide antagonist of CXCR2 inhibits acute and chronic models of arthritis in the rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

5-amino salicylic acid bound nanoparticles for the therapy of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

Nanoparticles in inflammatory bowel disease: particle targeting versus pH-sensitive delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

Nanoparticles enhance therapeutic efficiency by selectively increased local drug dose in experimental colitis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

Characterization of the molecular interactions of interleukin-8 (CXCL8), growth related oncogen alpha (CXCL1) and a non-peptide antagonist (SB 225002) with the human CXCR2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

Receptor binding mode and pharmacological characterization of a potent and selective dual CXCR1/CXCR2 non-competitive allosteric inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

A chemokine receptor CXCR2 macromolecular complex regulates neutrophil functions in inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

A common intracellular allosteric binding site for antagonists of the CXCR2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

CXCL8(3-73)K11R/G31P antagonizes the neutrophil chemoattractants present in pasteurellosis and mastitis lesions and abrogates neutrophil influx into intradermal endotoxin challenge sites in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213520110

21 January 2018

Identifiers

DOI

10.1177/1535370213520110

1 reference

30 August 2017

1 reference